Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Background Immune effector cell-associated neurotoxicity syndrome (ICANS) is a common adverse event of CD19-directed chimeric antigen receptor (CAR) T cell therapy. Other neurological adverse events, however, have not methodically been described and studied. Furthermore, safety data on CAR-T cell th...
Saved in:
Main Authors: | Christian Koch, Patrick Roth, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e006059.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiogenic Shock and Guillain–Barré Syndrome as the First Manifestations of Pheochromocytoma
by: Maryam Heidarpour, et al.
Published: (2021-01-01) -
Isolated Bilateral Ptosis as an Early Sign of Guillain-Barré Syndrome
by: Yahia Z. Imam, et al.
Published: (2013-01-01) -
Successful treatment of anorexia nervosa and alleviation of chronic Guillain Barré syndrome
by: Andreas Richterich, et al.
Published: (2011-02-01) -
A Case of Systemic Lupus Erythematosus Presenting as Guillain-Barré Syndrome
by: Helen Chioma Okoh, et al.
Published: (2015-01-01) -
Guillain-Barré Syndrome due to CMV Reactivation after Cardiac Transplantation
by: Christina Maria Steger, et al.
Published: (2012-01-01)